Compugen Ltd. (CGEN)
2.13
+0.01
(+0.47%)
USD |
NASDAQ |
Oct 09, 16:00
2.13
0.00 (0.00%)
After-Hours: 20:00
Compugen Profit Margin (Quarterly) : -269.3% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -269.3% |
| March 31, 2026 | -352.4% |
| December 31, 2025 | 84.42% |
| September 30, 2025 | -369.1% |
| June 30, 2025 | -584.1% |
| March 31, 2025 | -314.4% |
| December 31, 2024 | -415.8% |
| September 30, 2024 | 7.45% |
| June 30, 2024 | -31.68% |
| March 31, 2024 | -284.0% |
| December 31, 2023 | 29.03% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | -41.23% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | -102.6% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -428.2% |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | -39.88% |
| June 30, 2018 | |
| March 31, 2018 | 1.04% |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | -16.02K% |
| September 30, 2016 | -11.12K% |
| June 30, 2016 | -1.34K% |
| March 31, 2016 | -9.25K% |
| December 31, 2015 | -5.68% |
| September 30, 2015 | -2.94K% |
| June 30, 2015 | -3.05K% |
| March 31, 2015 | -1.20K% |
| December 31, 2014 | -22.62% |
| September 30, 2014 | -314.0% |
| June 30, 2014 | -118.1% |
| March 31, 2014 | -88.98% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pluri, Inc. | -1.85K% |
| Evogene Ltd. | -458.5% |
| Scinai Immunotherapeutics Ltd. | -435.4% |
| CollPlant Biotechnologies Ltd. | -2.52K% |
| Regentis Biomaterials Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 46.19% |
| Return on Assets | 27.26% |
| Return on Invested Capital | 44.46% |
| Gross Profit Margin (Quarterly) | -3.54% |
| Operating Margin (Quarterly) | -339.6% |
| Return on Net Operating Assets | 922.1% |